‘The proven avoidance modalities are not accessible to any substantial proportion of the individuals who want them,’ said Fauci, one of the keynote loudspeakers at the 4th International AIDS Society Conference on HIV Pathogenesis and Treatment in Sydney, Australia, wednesday which runs through. ‘Although we are making main improvements in the usage of drugs, clearly prevention must be addressed in a very forceful way,’ he added. According to recent World Health Organization statistics, just 28 % of the world’s HIV/AIDS patients are receiving anti-retroviral medicines. Dr. Brian Gazzard, chairman of the British HIV Association, stated that while great advances have been produced in extending usage of anti-retrovirals, the disease is running rampant in elements of Asia and Africa still..
Accelrys announces acquisition of VelQuest Accelrys, Inc. , a respected scientific enterprise study and development software program and services company, today announced that it offers acquired privately-held VelQuest Corporation for $35 million within an all-cash transaction. VelQuest is the leader in paperless lab execution systems assisting current Good Manufacturing Procedures for FDA-regulated industries including pharmaceuticals and biotechnology institutions. Accelrys’ acquisition of VelQuest extends Accelrys’ software portfolio into the downstream pharmaceutical development Quality Assurance and Quality Control space, offering significant efficiency improvements, faster cycle times, lower operational costs and decreased compliance risks for regulated life sciences organizations.